$SCYX
SCYNEXIS Inc

2019 Q3 Form 10-Q Financial Statement

#000156459019042606 Filed on November 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q4 2018 Q3
Revenue $0.00 $60.00K $64.00K
YoY Change -100.0% 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.480M $2.150M $2.433M
YoY Change 1.93% 17.49% 21.41%
% of Gross Profit
Research & Development $9.276M $6.700M $3.933M
YoY Change 135.85% 24.07% -11.8%
% of Gross Profit
Depreciation & Amortization $30.00K $30.00K $20.00K
YoY Change 50.0%
% of Gross Profit
Operating Expenses $11.76M $8.850M $6.366M
YoY Change 84.67% 22.41% -1.5%
Operating Profit -$11.76M -$6.302M
YoY Change 86.54% -1.52%
Interest Expense $203.0K $4.000M $435.0K
YoY Change -53.33% -1030.23% -121.75%
% of Operating Profit
Other Income/Expense, Net $3.815M $4.300M $6.653M
YoY Change -42.66% -4400.0% -432.32%
Pretax Income -$7.940M -$4.790M $350.0K
YoY Change -2368.57% -36.89% -104.17%
Income Tax -$6.740M
% Of Pretax Income
Net Earnings -$7.941M $1.940M $351.0K
YoY Change -2362.39% -125.56% -104.18%
Net Earnings / Revenue 3233.33% 548.44%
Basic Earnings Per Share -$1.43 $0.01
Diluted Earnings Per Share -$1.45 $404.2K $0.01
COMMON SHARES
Basic Shares Outstanding 5.570M 46.99M
Diluted Shares Outstanding 6.708M 47.03M

Balance Sheet

Concept 2019 Q3 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.10M $44.20M $49.50M
YoY Change -43.23% 0.68% 3.77%
Cash & Equivalents $11.89M $11.44M $16.08M
Short-Term Investments $16.50M $32.70M $33.40M
Other Short-Term Assets $51.00K $54.00K $51.00K
YoY Change 0.0% -40.66% -40.7%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.00M $51.46M $50.24M
YoY Change -42.27% 14.46% 3.15%
LONG-TERM ASSETS
Property, Plant & Equipment $3.700M $516.0K $462.0K
YoY Change 700.87% 12800.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.200M $812.0K $573.0K
YoY Change 109.42% 41.96% -36.33%
Total Long-Term Assets $4.800M $1.707M $1.415M
YoY Change 239.22% 91.8% 53.97%
TOTAL ASSETS
Total Short-Term Assets $29.00M $51.46M $50.24M
Total Long-Term Assets $4.800M $1.707M $1.415M
Total Assets $33.80M $53.17M $51.65M
YoY Change -34.56% 15.97% 4.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.800M $3.653M $1.975M
YoY Change 193.67% -4.7% 7.81%
Accrued Expenses $2.300M $2.103M $1.403M
YoY Change 63.93% 23.34% -19.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $7.349M
YoY Change -100.0% 157.95%
Total Short-Term Liabilities $8.100M $5.877M $11.09M
YoY Change -26.93% -42.06% 66.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $15.08M $7.617M
YoY Change -100.0% 46.38% -34.91%
Other Long-Term Liabilities $7.000M $1.000M $5.100M
YoY Change 37.25% -75.0% 27.5%
Total Long-Term Liabilities $0.00 $15.08M $7.617M
YoY Change -100.0% 46.38% -34.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.100M $5.877M $11.09M
Total Long-Term Liabilities $0.00 $15.08M $7.617M
Total Liabilities $27.67M $21.95M $23.77M
YoY Change 16.41% -10.21% 6.33%
SHAREHOLDERS EQUITY
Retained Earnings -$257.0M -$217.7M -$219.7M
YoY Change 16.99% 6.07% 11.13%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.143M $31.23M $27.88M
YoY Change
Total Liabilities & Shareholders Equity $33.82M $53.17M $51.65M
YoY Change -34.53% 15.97% 4.09%

Cashflow Statement

Concept 2019 Q3 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$7.941M $1.940M $351.0K
YoY Change -2362.39% -125.56% -104.18%
Depreciation, Depletion And Amortization $30.00K $30.00K $20.00K
YoY Change 50.0%
Cash From Operating Activities -$10.40M -$6.050M -$6.150M
YoY Change 69.11% 17.25% 17.14%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$90.00K -$70.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$420.0K $680.0K $15.01M
YoY Change -102.8% -89.63% 408.81%
Cash From Investing Activities -$420.0K $600.0K $14.94M
YoY Change -102.81% -90.85% 406.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.240M 820.0K 520.0K
YoY Change 523.08% -37.88% -85.56%
NET CHANGE
Cash From Operating Activities -10.40M -6.050M -6.150M
Cash From Investing Activities -420.0K 600.0K 14.94M
Cash From Financing Activities 3.240M 820.0K 520.0K
Net Change In Cash -7.580M -4.630M 9.310M
YoY Change -181.42% -270.22% 616.15%
FREE CASH FLOW
Cash From Operating Activities -$10.40M -$6.050M -$6.150M
Capital Expenditures $0.00 -$90.00K -$70.00K
Free Cash Flow -$10.40M -$5.960M -$6.080M
YoY Change 71.05% 15.5% 15.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001178253
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Trading Symbol
TradingSymbol
SCYX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11439000
CY2018Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
32718000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7251000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
55000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
51463000
CY2019Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
121000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15082000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27434000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812000
CY2018Q4 us-gaap Deferred Costs
DeferredCosts
106000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
273000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
516000
CY2019Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3629000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3378000
CY2019Q3 us-gaap Liabilities
Liabilities
27673000
CY2019Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2019Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
57000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
263056000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256970000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6143000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33816000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57362453
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57362453
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9276000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3933000
CY2018Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-21193000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1045000
CY2019Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
306000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14858000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6528000
us-gaap Operating Expenses
OperatingExpenses
21386000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
314000
us-gaap Interest Income Other
InterestIncomeOther
697000
us-gaap Interest Expense
InterestExpense
1211000
us-gaap Interest Income Other
InterestIncomeOther
680000
CY2018Q3 us-gaap Interest Expense
InterestExpense
435000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2643000
CY2019Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2324000
CY2018Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-7941000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2480000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2433000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7501000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
11756000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
6366000
us-gaap Operating Expenses
OperatingExpenses
34935000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11756000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6302000
us-gaap Operating Income Loss
OperatingIncomeLoss
-34814000
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2018Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
103000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
879000
CY2019Q3 us-gaap Interest Income Other
InterestIncomeOther
170000
CY2018Q3 us-gaap Interest Income Other
InterestIncomeOther
260000
CY2019Q3 us-gaap Interest Expense
InterestExpense
203000
us-gaap Interest Expense
InterestExpense
774000
CY2019Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1830000
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6931000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
223000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3815000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6653000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4438000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
351000
us-gaap Net Income Loss
NetIncomeLoss
-39252000
us-gaap Net Income Loss
NetIncomeLoss
-14410000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55697391
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46988844
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52787578
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42519585
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67079391
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47025503
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52787578
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42519585
us-gaap Profit Loss
ProfitLoss
-39252000
us-gaap Profit Loss
ProfitLoss
-14410000
us-gaap Depreciation
Depreciation
85000
us-gaap Depreciation
Depreciation
19000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1387000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1351000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
61000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
119000
scyx Write Off Of Deferred Filing Costs
WriteOffOfDeferredFilingCosts
0
scyx Write Off Of Deferred Filing Costs
WriteOffOfDeferredFilingCosts
230000
scyx Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
127000
scyx Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
0
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-6485000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-323000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2345000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2169000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-121000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-193000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24661000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22265000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
54700000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
61042000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
477000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
38504000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
61963000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16196000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1398000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10069000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30699000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
302000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
2136000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
49000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
39000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
16000000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1253000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15973000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8590000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28602000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
125000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4939000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11767000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11469000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11892000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16408000
us-gaap Interest Paid Net
InterestPaidNet
850000
us-gaap Interest Paid Net
InterestPaidNet
1176000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
736000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
601000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3365000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
6000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
84000
us-gaap Stock Issued1
StockIssued1
2984000
us-gaap Stock Issued1
StockIssued1
0
CY2018Q3 scyx Aggregate Amount Receivable Upon Exercise Of Warrants
AggregateAmountReceivableUponExerciseOfWarrants
28600000
CY2018Q3 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
175000000
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
13198075
CY2018Q3 scyx Warrants Expiration Date
WarrantsExpirationDate
2019-03-14
CY2019Q3 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
163800000
CY2019Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-1815000
CY2018Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9756000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
351000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-39252000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14410000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
36659
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
11382000
CY2018Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18486864
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29722758
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29868864
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29759417
CY2018Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
32718000
CY2019Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
16487000
CY2018Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
14000
CY2019Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
13000
CY2018Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
15000
CY2019Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
10000
CY2018Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
32717000
CY2019Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
16490000
CY2019Q3 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
303000
CY2018Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
245000
CY2019Q3 us-gaap Prepaid Insurance
PrepaidInsurance
412000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
200000
CY2019Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
88000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
20000
CY2019Q3 scyx Net Operating Loss Sale Receivable Current
NetOperatingLossSaleReceivableCurrent
0
CY2018Q4 scyx Net Operating Loss Sale Receivable Current
NetOperatingLossSaleReceivableCurrent
6732000
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
51000
CY2019Q3 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
677000
CY2018Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
587000
CY2019Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1065000
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1197000
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21000
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
483000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company must furnish a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which will be reduced by fifty-five thousand dollars every two years for ten years after the commencement of the lease
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3365000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3368000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
us-gaap Operating Lease Cost
OperatingLeaseCost
498000
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
8000
us-gaap Variable Lease Cost
VariableLeaseCost
25000
CY2019Q3 us-gaap Lease Cost
LeaseCost
174000
us-gaap Lease Cost
LeaseCost
523000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
111000
us-gaap Operating Lease Payments
OperatingLeasePayments
330000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M2D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
498000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
508000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
518000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
529000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
716000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4203000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6972000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
167000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
507000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
517000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
527000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
715000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4263000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6696000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3409000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3345000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3287000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3604000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
26553000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
458000
CY2018Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
21000
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
498000
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-2000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
470053
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5189860
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2761275
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5189860
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
27879000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21410000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1351000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
39000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19498000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-9000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
10402000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
449000
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3206000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-2000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
37000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9761000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2984000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-11000
CY2019Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
30885369
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
30404957
CY2019Q3 scyx Fair Value Of Liabilities
FairValueOfLiabilities
3600000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4052913
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1629500
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22500
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.37
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.26
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.96
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.32
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.09
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y11M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y10M2D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
75000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
47000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
75000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
449000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
458000
CY2019Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2018Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2019Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000
CY2018Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0

Files In Submission

Name View Source Status
0001564590-19-042606-index-headers.html Edgar Link pending
0001564590-19-042606-index.html Edgar Link pending
0001564590-19-042606.txt Edgar Link pending
0001564590-19-042606-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20190930.htm Edgar Link pending
scyx-20190930.xml Edgar Link completed
scyx-20190930.xsd Edgar Link pending
scyx-20190930_cal.xml Edgar Link unprocessable
scyx-20190930_def.xml Edgar Link unprocessable
scyx-20190930_lab.xml Edgar Link unprocessable
scyx-20190930_pre.xml Edgar Link unprocessable
scyx-ex311_7.htm Edgar Link pending
scyx-ex312_6.htm Edgar Link pending
scyx-ex321_9.htm Edgar Link pending
Show.js Edgar Link pending